VIVO Cannabis Inc (formerly ABcann Global)[1] is a Canadian licensed cannabis producer, headquartered in Napanee, Ontario. Prior to being acquired by MediPharm Labs Corp., VIVO traded on the Toronto Stock Exchange as VIVO.
History
VIVO received two of the first 15 licences by Health Canada in 2014.[2] It became a publicly traded company in April 2017 on the TSX Venture Exchange. In August 2017, the company received a $15 million investment by Cannabis Wheaton to fund the second production facility at its 65-acre property in Napanee.[3] Effective January 24, 2020, the company's stocks were moved from the TSX Venture Exchange to the Toronto Stock Exchange.[4][5]